Search
for
Sort by
Research 931–960 of 1000+
- Anti-hair loss and hair care properties from tropical halophyte, seablite (Suaeda maritima) root extract
- Persistent Gynecomastia due to Short-term Low-dose Finasteride for Androgenetic Alopecia
- Dihydrotestosterone induces arterial stiffening in female mice
- Protective role of hesperidin in finasteride-induced testicular toxicity in adult male Wistar rats: Insights into oxidative stress, apoptosis, and ultrastructure of seminiferous tubules
- Topical Finasteride: A Comprehensive Review of Androgenetic Alopecia Management for Men and Women
- A microfluidic application for mass production of drug-loaded polymeric microspheres for a long-acting injectable with IVL-DrugFluidic®, a novel microfluidic microsphere manufacturing platform technology
- MON-014 Evaluation of Healthcare of Gender-Dysphoric Veterans in the Veterans Affairs Northern California Health Care System (VANCHCS)
- MON-218 Inflammatory Role of Sex Steroids in Hidradenitis Suppurativa: An Androgenic Phenotype
- Improvement of androgenic alopecia by extracellular vesicles secreted from hyaluronic acid-stimulated induced mesenchymal stem cells
- ST14 interacts with TMEFF1 and is a predictor of poor prognosis in ovarian cancer
- Development of validated methods for the simultaneous quantification of Finasteride and Tadalafil in newly launched FDA-approved therapeutic combination: greenness assessment using AGP, analytical eco-scale, and GAPI tools
- Urological Drug Price Stewardship: Potential Cost Savings Based on the Mark Cuban Cost Plus Drug Company Model
- Herbs for Benign Prostatic Hyperplasia
- Persistent erectile dysfunction in men exposed to the 5α-reductase inhibitors, finasteride, or dutasteride
- BPH: costs and treatment outcomes.
- Cognitive effects of testosterone and finasteride administration in older hypogonadal men.
- 5α-reductase inhibitors impact prognosis of urothelial carcinoma
- Finasteride and Erectile Dysfunction in Patients with Benign Prostatic Hyperplasia or Male Androgenetic Alopecia
- Post-finasteride syndrome
- Evidence for the efficacy and safety of tadalafil and finasteride in combination for the treatment of lower urinary tract symptoms and erectile dysfunction in men with benign prostatic hyperplasia
- Selective androgen receptor modulators: a critical appraisal
- Oral Presentations: Abstracts of the Urological Society of Australia and New Zealand Annual Scientific Meeting, 25–28 February 2023, Melbourne, Australia
- Food Administration and Not Genetic Variants Causes Pharmacokinetic Variability of Tadalafil and Finasteride
- Post-finasteride Syndrome: A Review of Current Literature
- 5α-Reductase Isoenzymes: From Neurosteroid Biosynthesis to Neuropsychiatric Outcomes
- SRD5A2 and emerging therapies in androgen-driven disorders
- Bioprospecting of Potential Inhibitors of 5alpha Reductase 2 Inhibitors from Relevant Ethno-pharmacological Plants via In Silico Techniques
- European Society of Endocrinology Clinical Practice Guideline: Endocrine work-up in obesity
- Phase I Study of the Hedgehog Pathway Inhibitor IPI-926 in Adult Patients with Solid Tumors
- Intracrine androgen biosynthesis, metabolism and action revisited